KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biogen (BIIB) Receivables - Other (2018 - 2023)

Biogen has reported Receivables - Other over the past 9 years, most recently at $6.3 million for Q1 2023.

  • Quarterly results put Receivables - Other at $6.3 million for Q1 2023, up 8.62% from a year ago — trailing twelve months through Mar 2023 was $6.3 million (up 8.62% YoY), and the annual figure for FY2022 was $2.0 million, down 99.3%.
  • Receivables - Other for Q1 2023 was $6.3 million at Biogen, up from $2.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for BIIB hit a ceiling of $285.4 million in Q4 2021 and a floor of $1.8 million in Q3 2022.
  • Median Receivables - Other over the past 5 years was $5.8 million (2022), compared with a mean of $51.1 million.
  • Biggest five-year swings in Receivables - Other: surged 88.88% in 2021 and later tumbled 99.3% in 2022.
  • Biogen's Receivables - Other stood at $85.0 million in 2019, then surged by 77.76% to $151.1 million in 2020, then surged by 88.88% to $285.4 million in 2021, then tumbled by 99.3% to $2.0 million in 2022, then surged by 215.0% to $6.3 million in 2023.
  • The last three reported values for Receivables - Other were $6.3 million (Q1 2023), $2.0 million (Q4 2022), and $1.8 million (Q3 2022) per Business Quant data.